title: Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections.
authors.forename: L L
authors.initials: LL
authors.lastname: Livornese
authors.forename: M
authors.initials: M
authors.lastname: Gold
authors.forename: C C
authors.initials: CC
authors.lastname: Johnson
authors.forename: R
authors.initials: R
authors.lastname: Measley
authors.forename: D
authors.initials: D
authors.lastname: Kaye
authors.forename: O
authors.initials: O
authors.lastname: Korzeniowski
authors.forename: M L
authors.initials: ML
authors.lastname: Walsh
authors.forename: C
authors.initials: C
authors.lastname: Samel
authors.forename: M
authors.initials: M
authors.lastname: Hessen
authors.forename: M E
authors.initials: ME
authors.lastname: Levison
mesh_terms: D000328:Adult; D000368:Aged; D016470:Bacteremia / Q000188:drug therapy; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D017334:Teicoplanin / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy*
chemical_list: D017334:Teicoplanin